Background – PDA Global
PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry. Today, coordinated through its headquarters and manufacturing training facility in Bethesda, Maryland, and Europe office in Berlin, Germany, PDA volunteers worldwide carry out its mission of promoting the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.
PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and other documents and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical products technology.
With more than 10,500 individual members worldwide, PDA draws its strength from the technical expertise of its membership. Conferences, meetings, and courses bring together pharmaceutical manufacturers, suppliers, users, academics, and regulatory officials to discuss and boost issues of mutual interest. These exchanges of technical knowledge, expertise, and best practices assist the advancement of pharmaceutical science and technology in the interest of public health.
The PDA Israel Chapter
The PDA Israel Chapter was founded in 1997 and is made up of the Executive committee, including the president, president-elect, treasurer and liaison with international PDA, and the Steering Committee.
Executive Committee
For the Industry - By the Industry
Karin Baer
President
VP Quality, NeuroDerm
Galit Afik
President Elect & Liaison with international PDA
QA Director, R&D & CMO, Kamada Ltd.
Rachel Karpel
Treasurer
Consultant, Karpel Pharma Consulting
Raphy Bar
Consultant, BR Consulting
Meir Batito
Site Quality Head, Teva Pharmaceutical Industries
Ofra Levy-Hacham
VP Clinical and Regulatory Affairs, Sol-Gel Technologies
Drorit Lew
QC Director, MediWound Ltd.
Sasha Nezlin
VP Quality, UroGen Pharma
Shlomo Sackstein
CEO, Biopuremax
Yael Libal-Wexler
Quality Systems Manager, BioTechnology General (BTG)
Join PDA Israel’s Executive Committee
Become an active leader in the pharmaceutical and biotechnology community by joining PDA Israel’s Executive Committee. As a committee member, you’ll have the opportunity to influence industry initiatives, contribute to knowledge-sharing, and help shape the future of pharmaceutical science and regulations in Israel. Join us in making a meaningful impact!